Diagnos Enterprise Value Over E B I T D A from 2010 to 2024
| ADK Stock | CAD 0.29 0.01 3.57% |
Enterprise Value Over EBITDA | First Reported 2010-12-31 | Previous Quarter (9.40) | Current Value (9.87) | Quarterly Volatility 4.36448804 |
Check Diagnos financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Diagnos' main balance sheet or income statement drivers, such as Depreciation And Amortization of 118.2 K, Total Revenue of 161.7 K or Other Operating Expenses of 3.1 M, as well as many indicators such as Price To Sales Ratio of 155, Dividend Yield of 0.0 or Days Sales Outstanding of 38.12. Diagnos financial statements analysis is a perfect complement when working with Diagnos Valuation or Volatility modules.
Diagnos | Enterprise Value Over E B I T D A |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Diagnos Stock Analysis
When running Diagnos' price analysis, check to measure Diagnos' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Diagnos is operating at the current time. Most of Diagnos' value examination focuses on studying past and present price action to predict the probability of Diagnos' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Diagnos' price. Additionally, you may evaluate how the addition of Diagnos to your portfolios can decrease your overall portfolio volatility.